01 December 2013

10 HIV/AIDS Stories That Defined 2013 in the U.S.

Making this year's list: The Food and Drug Administration has approved the antiretroviral medication Truvada to reduce the risk of HIV infection in uninfected individuals. That biomedical prevention strategy is known as pre-exposure prophylaxis or PrEP.

Truvada becomes the first medication ever to be approved for HIV prevention in adults, marking a major milestone in the 30-plus years of the global epidemic. But many questions remain around adherence, risk, access .. as well as the outrageous $14,000 annual price tag. Meanwhile, there are promising developments in the decades-long quest for an HIV vaccine.